(Q86845291)
Statements
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis (English)
Steven R Feldman
Yang Zhao
Prakash Navaratnam
Howard S Friedman
Jackie Lu